IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CBDW

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Cash & Equivalents0.000.010.000.000.000.000.000.030.080.020.050.030.030.220.110.000.020.010.01
Accounts Receivable--------------0.000.000.00------------0.000.000.00
Inventory------------0.000.000.070.070.070.130.130.110.110.110.090.030.03
Total Current Assets0.040.070.020.010.030.000.010.040.200.140.150.200.180.36----------
Total Non-current Assets*0.000.000.000.000.000.000.000.000.000.000.000.000.000.07----------
Total Assets0.040.070.020.010.030.000.010.040.200.140.150.200.180.430.230.110.110.040.04
Accounts Payable--------------0.470.490.40------------------
Short-term Debt2.251.630.930.490.060.110.190.25----------------------
Total Current Liabilities3.984.153.242.902.572.352.212.140.900.730.611.561.000.900.830.720.600.400.22
Long-term Debt2.592.442.061.971.921.82----1.221.02------------------
Total Non-current Liabilities*0.000.000.000.000.000.000.000.001.221.020.950.000.000.000.000.000.000.000.04
Total Liabilities*3.984.153.242.902.572.352.212.142.121.751.561.561.000.900.830.720.600.400.26
Retained Earnings(9.42)(9.30)(8.23)(7.74)(7.36)(7.15)(6.94)(6.62)(3.05)(2.71)(2.42)(2.23)(1.67)(1.13)(0.84)(0.69)(0.57)(0.45)(0.30)
Total Stockholder Equity(3.94)(4.08)(3.22)(2.89)(2.54)(2.35)(2.20)(2.10)(1.92)(1.61)(1.41)(1.36)(0.82)(0.48)(0.60)(0.60)(0.48)(0.36)(0.22)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Total Revenue----0.000.000.000.000.000.000.000.010.000.000.000.000.000.000.000.000.01
Cost of Revenue----0.000.000.000.000.000.000.000.01-0.000.000.000.000.010.000.000.000.00
Gross Profit----0.000.000.000.000.000.000.00-0.000.000.00-0.00-0.00(0.01)0.000.000.000.01
Selling, General & Admin0.150.170.080.110.120.170.033.220.290.580.430.520.470.29(0.29)0.120.120.150.10
Total Operating Expenses0.150.170.080.110.120.170.033.250.290.580.430.520.530.290.150.120.120.150.10
Operating Income(0.15)(0.17)(0.08)(0.11)(0.12)(0.17)(0.03)(3.25)(0.29)(0.58)(0.42)(0.52)--------------
Interest Expense0.580.540.510.320.060.06(0.90)0.100.13--------------------
Pretax Income(0.12)(1.07)(0.49)(0.38)(0.21)(0.21)(0.32)(3.57)(0.34)(0.29)(1.32)0.57(0.53)(0.29)(0.15)(0.12)(0.12)(0.15)(0.10)
Tax Provision0.000.000.000.000.000.000.000.000.000.000.000.000.000.00--0.000.000.000.00
Net Income(0.12)(1.07)(0.49)(0.38)(0.21)(0.21)(0.32)(3.57)(0.34)(0.29)(0.19)(0.57)(0.53)(0.29)(0.45)(0.12)(0.12)0.15(0.14)
Diluted EPS0.000.00(0.01)0.000.000.000.03------------------------
← Scroll for more columns →

Cash Flow Statement

(in thousands USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Operating Cash Flow(304.20)(422.06)(111.50)(72.60)(119.01)(157.68)(180.29)(263.67)(181.60)(265.44)(155.35)(167.66)(189.12)(234.98)(142.15)(137.74)(184.37)(145.88)
Investing Cash Flow0.000.000.000.000.000.000.000.000.000.000.000.00(21.50)(65.00)0.000.000.000.00
Financing Cash Flow295.45431.10110.5071.73120.59155.89155.58215.44240.73232.37169.98175.0017.48415.02245.67120.00195.00145.00
← Scroll for more columns →